118 related articles for article (PubMed ID: 2467329)
1. Exocrine pancreatic secretion: effect of subarachnoidal application of cholecystokinin octapeptide in rats.
Ormai S; Korányi L; Sasvári M; Endröczi E
Regul Pept; 1988 Oct; 23(1):51-5. PubMed ID: 2467329
[TBL] [Abstract][Full Text] [Related]
2. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
Shiratori K; Watanabe S; Takeuchi T
Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester attenuates cholecystokinin-stimulated amylase release in pancreatic acini of rats.
Lee PC; Leung YK; Srimaruta N; Cumella J; Rossi T
Biochim Biophys Acta; 1987 Oct; 931(1):101-9. PubMed ID: 2443187
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low affinity CCK receptors.
Menozzi D; Stark HA; Martinez J; Jensen RT; Gardner JD
Peptides; 1989; 10(2):337-41. PubMed ID: 2474153
[TBL] [Abstract][Full Text] [Related]
7. Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.
O'Rourke MF; Reidelberger RD; Solomon TE
Am J Physiol; 1990 Feb; 258(2 Pt 1):G179-84. PubMed ID: 1689547
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of alcohol administration on the trophic effect of soybean trypsin inhibitor and cholecystokinin octapeptide in rat.
Pap A; Nagy I; Takács T; Hajnal F; Tóth G; Varró V
Int J Pancreatol; 1989 Oct; 5(3):263-72. PubMed ID: 2476519
[TBL] [Abstract][Full Text] [Related]
9. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
10. High-affinity CCK receptors are coupled to phospholipase A2 pathways to mediate pancreatic amylase secretion.
Tsunoda Y; Owyang C
Am J Physiol; 1995 Sep; 269(3 Pt 1):G435-44. PubMed ID: 7573455
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydrocortisone and cholecystokinin-octapeptide on neonatal rat pancreas.
Werlin SL; Stefaniak J
J Pediatr Gastroenterol Nutr; 1982; 1(4):591-5. PubMed ID: 6193263
[TBL] [Abstract][Full Text] [Related]
12. Stimulus-secretion coupling in the developing exocrine pancreas: secretory responsiveness to cholecystokinin.
Chang A; Jamieson JD
J Cell Biol; 1986 Dec; 103(6 Pt 1):2353-65. PubMed ID: 3023399
[TBL] [Abstract][Full Text] [Related]
13. Effect of somatostatin and octreotide acetate on OP-CCK-stimulated exocrine secretion in the denervated canine pancreas.
Garvin PJ; Burton FR; Reese JC; Dysarz FA; Lingle D; Niehoff ML; Pandya PK; Presti ME
Pancreas; 1996 Oct; 13(3):304-10. PubMed ID: 8884853
[TBL] [Abstract][Full Text] [Related]
14. Effects of phorbol ester on cholecystokinin octapeptide-evoked exocrine pancreatic secretion in the rat.
Francis LP; Camello PJ; Singh J; Salido GM; Madrid JA
J Physiol; 1990 Dec; 431():27-37. PubMed ID: 1712842
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
16. Effect of Bt2cGMP on action of cholecystokinin in isolated perfused rat pancreas.
Otsuki M; Okabayashi Y; Ohki A; Nakamura T; Tani S; Fujii M; Oka T; Sankaran H; Baba S
Am J Physiol; 1986 Sep; 251(3 Pt 1):G293-9. PubMed ID: 2428254
[TBL] [Abstract][Full Text] [Related]
17. Decreased pancreatic CCK receptor binding and CCK-stimulated amylase release in Zucker obese rats.
McLaughlin CL; Peikin SR; Baile CA
Physiol Behav; 1984 Jun; 32(6):961-5. PubMed ID: 6208569
[TBL] [Abstract][Full Text] [Related]
18. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
[TBL] [Abstract][Full Text] [Related]
19. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
[TBL] [Abstract][Full Text] [Related]
20. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
Taniguchi H; Nagasaki M; Tamaki H
Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
